More than 50% of Covid-19 cases in the United States are African-Americans or Latinos, yet they make up only 15% of the participants in the first Phase III vaccine trial in the United States, together developed by biotech company Moderna and the National Institutes of Health. In fact, National Institutes …
Read More »